Melatonin is a hormone synthesised and secreted by the pineal gland and other organs. Its secretion, controlled by an endogenous circadian cycle, has been proven to exert immunological, anti-oxidant, and anti-inflammatory effects that can be beneficial in the treatment of certain dental diseases. This article is aimed at carrying out a review of the literature published about the use of melatonin in the dental field and summarising its potential effects. In this review article, an extensive search in different databases of scientific journals was performed with the objective of summarising all of the information published on melatonin use in dental diseases, focussing on periodontal diseases and dental implantology. Melatonin released in a natural way into the saliva, or added as an external treatment, may have important implications for dental disorders, such as periodontal disease, as well as in the osseointegration of dental implants, due to its anti-inflammatory and osseoconductive effects. Melatonin has demonstrated to have beneficial effects on dental pathologies, although further research is needed to understand the exact mechanisms of this molecule.

GBR with bone substitute blocks lead to higher ridge dimensions than empty controls. The equine block with CM rendered the most favorable outcomes in hard and soft tissue contours followed by DBBM block and DBBM granulate with CM.

OBJECTIVE To assess whether or not peri-implant soft tissue dimensions and hard tissue integration of loaded zirconia implants are similar to those of a titanium implant. MATERIALS AND METHODS In six dogs, two one-piece zirconia implants (VC, ZD), a two-piece zirconia implant (BPI) and a control one-piece titanium implant (STM) were randomly placed. CAD/CAM crowns were cemented at 6 months. Six months later, animals were killed and histomorphometric analyses were performed, including: the level of the mucosal margin, the extent of the peri-implant mucosa, the marginal bone loss and the bone-to-implant contact (BIC). Means of outcomes variables were calculated together with their corresponding 95% confidence intervals. RESULTS In general, the mucosal margin was located coronally to the implant shoulder. The buccal peri-implant mucosa ranged between 2.64 ± 0.70 mm (VC) and 3.03 ± 1.71 mm (ZD) (for all median comparisons p > 0.05). The relative marginal bone loss ranged between 0.65 ± 0.61 mm (BPI) and 1.73 ± 1.68 mm (ZD) (buccal side), and between 0.55 ± 0.37 mm (VC) and 1.69 ± 1.56 mm (ZD) (lingual side) (p > 0.05). The mean BIC ranged between 78.6% ± 17.3% (ZD) and 87.9% ± 13.6% (STM) without statistically significant differences between the groups (p > 0.05). CONCLUSIONS One-and two-piece zirconia rendered similar peri-implant soft tissue dimensions and osseointegration compared to titanium implants that were placed at 6 months of loading. Zirconia implants, however, exhibited a relatively high fracture rate. Scientific rationale for the study: Patient demands include alternatives to classic titanium dental implants. For that purpose, zirconia implants were developed and brought on the market. Even though the number of dental implants made of zirconia is increasing, preclinical and clinical data are scarce comparing titanium and zirconia one-and two-piece dental implants on a soft and hard tissue level or with or without a loading period.Principal findings: After a loading period of 6 months one-and two-piece zirconia and one-piece titanium dental implants render similar peri-implant soft tissue dimensions in terms of the extent of the junctional epithelium and the peri-implant mucosa. The relative marginal bone loss depends on the individual implant design. Fractures of zirconia implants were frequent, however. Practical implications:Within the limitations of this study zirconia and titanium dental implants render similar hard and soft tissue integration. Zirconia implants should be compared to titanium dental implants in long-term randomized controlled clinical trials. 3 AbstractObjective: To assess whether or not peri-implant soft tissue dimensions and hard tissue integration of loaded zirconia implants are similar to those of a titanium implant. Materials and methods:In 6 dogs, two one-piece zirconia implants (VC, ZD), a two-piece zirconia implant (BPI) and a control one-piece titanium implant (STM) were randomly placed.CAD/CAM crowns were cemented at 6 months. Six months later, animals were sacri...

Alloplastic calcium phosphate bone substitutes such as hydroxyapatite (HA) and tricalcium phosphate (TCP) have been studied extensively due to their composition closely resembling the inorganic phase of bone tissue. On the same way, by manipulating the HA/TCP ratio it may be possible to change the substitution rate and the bioactivity of these materials, an advantage which has brought them to clinical use in oral and orthopaedic surgery. In this work, we evaluated the histological response in bone of two biphasic calcium phosphate ceramics by varying the proportion of their components. All premolars of 6 beagle dogs were removed from both sides of the mandible. Three months later, four cylinders composed of 85% HA and 15% beta-TCP (BCP 1) were implanted in the right side of mandible and other four cylinders composed of 15% HA and 85% beta-TCP (BCP 2) were implanted in the left side of mandible of dogs for 4, 12 ad 26 weeks, respectively. Two dogs were used in each time point. The histological study indicated that both biphasic ceramic were biocompatible. The earlier and more quantity of bone formed in BCP 2 than in BCP 1 suggested that the first one had a higher osteoinductive potential than the second one in mandibular bone. The resorption of the phosphate phase and the subsequent migration of bone into the resorbed portions were detected in both biphasic ceramics although two processes appeared faster in BCP 2 than in BCP 1. These dates conclude that varying the components of our biphasic ceramic we improve its osteoinductive potential.

Azaspiracids (AZAs) are marine biotoxins produced by the dinoflagellate Azadinium spinosum that accumulate in several shellfish species. Azaspiracid poisoning (AZP) episodes have been described in humans due to ingestion of AZA-contaminated seafood. Therefore, the contents of AZA-1, AZA-2 and AZA-3, the best-known analogs of the group, in shellfish destined to human consumption have been regulated by food safety authorities of many countries to protect human health. In vivo and in vitro toxicological studies have described effects of AZAs at different cellular levels and on several organs, however, AZA target remains unknown. Very recently AZAs have been demonstrated to block the hERG cardiac potassium channel. In this study we explored the potential cardiotoxicity of AZA-2 in vivo. The effects of AZA-2 on rat electrocardiogram (ECG) and cardiac biomarkers were evaluated for cardiotoxicity signs besides corroborating the hERG blocking activity of AZA-2. Our results demonstrated that AZA-2 does not induce QT interval prolongation on rat ECGs in vivo, in spite of being an in vitro blocker of the hERG cardiac potassium channel. However, AZA-2 alters the heart electrical activity causing prolongation of PR intervals and the appearance of arrhythmias. More studies will be needed to clarify the mechanism by which AZA-2 causes these ECG alterations, however, the potential cardiotoxicity of AZAs demonstrated in this in vivo study should be taken into consideration when evaluating the possible threat that these toxins pose to human health, mainly for individuals with pre-existing cardiovascular disease when regulated toxin limits are exceeded.

No abstract

at 2-week interval (early healing), osseointegration had been influenced by different primary stability at implant installation, being slower in the oversized protocol (lower primary stability), which could be especially risky in challenging clinical situations, such as soft bone (class 3 and 4) and early/immediate loading. However, from 4 week on, these differences disappeared. Nevertheless, we have to consider that a direct transfer of the results of this animal study (time bone repair mechanisms) into clinic has to be done with caution.

BackgroundOsteoarthritis is thought to be the most prevalent chronic and disabling joint disease in animals and humans and its treatment is a major orthopaedic challenge because there is no ideal drug treatment to preserve joint structure and function, as well as to ameliorate the symptomatology of the disease. The aim of the present study was to assess, using histology, histomorphometry and micro-CT, the effects of the treatment with several drugs of the SYSADOA group and a bisphosphonate in a model of early osteoarthritis, comparing all the results obtained.MethodsOsteoarthritis was surgically induced by anterior cruciate ligament transection and partial meniscectomy on one knee of 56 rabbits; treatment was started three weeks after surgery and lasted 8 weeks; at the end of this period, the animals were sacrificed. Animals were divided into seven groups (8 animals each), one for each regimen of treatment (glucosamine sulfate, chondroitin sulfate, hyaluronic acid, diacerein, risedronate and a combination of risedronate and glucosamine) and one for the control (placebo-treated) group. Following sacrifice, femoral osteochondral cylinders and synovial membrane samples were obtained for their evaluation by qualitative and quantitative histology and micro-CT.ResultsThe model induced osteoarthritic changes in the knee joints and none of the treatments showed a significantly better efficacy over the others. Regarding cartilage thickness and volume, all the treatments achieved scores halfway between control groups, without statistical differences. Regarding the synovial membrane, diacerein and risedronate showed the best anti-inflammatory profile, whereas glucosamine and chondroitin did not present any effect standing the hyaluronic acid results between the others. Regarding the subchondral bone, there were no differences in thickness or volume, but risedronate, diacerein and hyaluronic acid seemed to have considerably modified the orientation of the trabecular lattice.ConclusionsOut of the different drugs evaluated in the study for OA treatment, diacerein and risedronate showed, in all the parameters measured, a better profile of effectiveness; hyaluronic acid ameliorated cartilage swelling and promoted bone formation, but with a poor synovial effect; and finally, chondroitin and glucosamine sulfate prevented cartilage swelling in a similar way to the others, but had no effect on cartilage surface, synovial membrane or subchondral bone.